Loading...
Immunotherapy updates in pancreatic cancer: are we there yet?
Pancreatic cancer is a lethal disease and remains one of the most resistant cancers to traditional therapies. Historically, chemotherapy or radiotherapy did not provide meaningful survival benefit in advanced pancreatic cancer. Gemcitabine and recently FOLFIRINOX (5-flourouracil, leucovorin, oxalipl...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3539275/ https://ncbi.nlm.nih.gov/pubmed/23323149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012462463 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|